The role of P16ink4a and P53 immunostaining in predicting recurrence of HG-CIN after conization treatment

Detalhes bibliográficos
Autor(a) principal: Fonseca,Fernanda Villar
Data de Publicação: 2016
Outros Autores: Tomasich,Flávio Daniel S., Jung,Juliana Elizabeth, Maestri,Carlos Afonso, Carvalho,Newton Sérgio de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista do Colégio Brasileiro de Cirurgiões
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-69912016000100035
Resumo: Objective: Io evaluate the expression of p16INK4a and p53 biomarkers in conization specimens from patients with high grade cervical intraepithelial neoplasia (HG-CIN), correlating them with the ability to predict the recurrence. Methods : we conducted a retrospective study of patients with HG-CIN in cervical biopsy treated with conization between January 1999 and January 2006 who had a minimum follow-up of 18 months. The expression of the p16 and p53 was assessed by tissue microarrays and correlated with disease recurrence. For analysis, we used the test of proportions (chi-square), considering value p<0.05, 95% CI and calculations of sensitivity, specificity and accuracy of these immunomarkers in predicting recurrence. Results : the series comprised 83 patients aged between 16 and 86 years (35±11.7), divided into two groups: 30 with HG-CIN recurrence (study group) and 53 without recurrence (control group). Mean age, parity, smoking and conization technique were similar in both groups. The p53 expression was present in 43% of the study group and 57% of the control group, and the p16 was present in 43% of the study group and in 57% of the control group (p>0.05). p53 had a positive predictive value (PPV) of 42% and negative predictive value (NPV) of 73%, sensitivity 70%, specificity of 47% and accuracy of 59%. The p16, PPV 42%, NPV 72%, sensitivity 66%, specificity of 49% and accuracy of 56%. Conclusion : immunohistochemistry expression of p53 and p16 showed low sensitivity and low specificity as predictors of HG-CIN recurrence after conization treatment.
id CBC-1_80358fdd15ded114f4220aec08cb241e
oai_identifier_str oai:scielo:S0100-69912016000100035
network_acronym_str CBC-1
network_name_str Revista do Colégio Brasileiro de Cirurgiões
repository_id_str
spelling The role of P16ink4a and P53 immunostaining in predicting recurrence of HG-CIN after conization treatmentCervical Intraepithelial NeoplasiaConizationRecurrenceBiological Markers Objective: Io evaluate the expression of p16INK4a and p53 biomarkers in conization specimens from patients with high grade cervical intraepithelial neoplasia (HG-CIN), correlating them with the ability to predict the recurrence. Methods : we conducted a retrospective study of patients with HG-CIN in cervical biopsy treated with conization between January 1999 and January 2006 who had a minimum follow-up of 18 months. The expression of the p16 and p53 was assessed by tissue microarrays and correlated with disease recurrence. For analysis, we used the test of proportions (chi-square), considering value p<0.05, 95% CI and calculations of sensitivity, specificity and accuracy of these immunomarkers in predicting recurrence. Results : the series comprised 83 patients aged between 16 and 86 years (35±11.7), divided into two groups: 30 with HG-CIN recurrence (study group) and 53 without recurrence (control group). Mean age, parity, smoking and conization technique were similar in both groups. The p53 expression was present in 43% of the study group and 57% of the control group, and the p16 was present in 43% of the study group and in 57% of the control group (p>0.05). p53 had a positive predictive value (PPV) of 42% and negative predictive value (NPV) of 73%, sensitivity 70%, specificity of 47% and accuracy of 59%. The p16, PPV 42%, NPV 72%, sensitivity 66%, specificity of 49% and accuracy of 56%. Conclusion : immunohistochemistry expression of p53 and p16 showed low sensitivity and low specificity as predictors of HG-CIN recurrence after conization treatment.Colégio Brasileiro de Cirurgiões2016-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-69912016000100035Revista do Colégio Brasileiro de Cirurgiões v.43 n.1 2016reponame:Revista do Colégio Brasileiro de Cirurgiõesinstname:Colégio Brasileiro de Cirurgiões (CBC)instacron:CBC10.1590/0100-69912016001008info:eu-repo/semantics/openAccessFonseca,Fernanda VillarTomasich,Flávio Daniel S.Jung,Juliana ElizabethMaestri,Carlos AfonsoCarvalho,Newton Sérgio deeng2016-04-11T00:00:00Zoai:scielo:S0100-69912016000100035Revistahttp://www.scielo.br/rcbcONGhttps://old.scielo.br/oai/scielo-oai.php||revistacbc@cbc.org.br1809-45460100-6991opendoar:2016-04-11T00:00Revista do Colégio Brasileiro de Cirurgiões - Colégio Brasileiro de Cirurgiões (CBC)false
dc.title.none.fl_str_mv The role of P16ink4a and P53 immunostaining in predicting recurrence of HG-CIN after conization treatment
title The role of P16ink4a and P53 immunostaining in predicting recurrence of HG-CIN after conization treatment
spellingShingle The role of P16ink4a and P53 immunostaining in predicting recurrence of HG-CIN after conization treatment
Fonseca,Fernanda Villar
Cervical Intraepithelial Neoplasia
Conization
Recurrence
Biological Markers
title_short The role of P16ink4a and P53 immunostaining in predicting recurrence of HG-CIN after conization treatment
title_full The role of P16ink4a and P53 immunostaining in predicting recurrence of HG-CIN after conization treatment
title_fullStr The role of P16ink4a and P53 immunostaining in predicting recurrence of HG-CIN after conization treatment
title_full_unstemmed The role of P16ink4a and P53 immunostaining in predicting recurrence of HG-CIN after conization treatment
title_sort The role of P16ink4a and P53 immunostaining in predicting recurrence of HG-CIN after conization treatment
author Fonseca,Fernanda Villar
author_facet Fonseca,Fernanda Villar
Tomasich,Flávio Daniel S.
Jung,Juliana Elizabeth
Maestri,Carlos Afonso
Carvalho,Newton Sérgio de
author_role author
author2 Tomasich,Flávio Daniel S.
Jung,Juliana Elizabeth
Maestri,Carlos Afonso
Carvalho,Newton Sérgio de
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Fonseca,Fernanda Villar
Tomasich,Flávio Daniel S.
Jung,Juliana Elizabeth
Maestri,Carlos Afonso
Carvalho,Newton Sérgio de
dc.subject.por.fl_str_mv Cervical Intraepithelial Neoplasia
Conization
Recurrence
Biological Markers
topic Cervical Intraepithelial Neoplasia
Conization
Recurrence
Biological Markers
description Objective: Io evaluate the expression of p16INK4a and p53 biomarkers in conization specimens from patients with high grade cervical intraepithelial neoplasia (HG-CIN), correlating them with the ability to predict the recurrence. Methods : we conducted a retrospective study of patients with HG-CIN in cervical biopsy treated with conization between January 1999 and January 2006 who had a minimum follow-up of 18 months. The expression of the p16 and p53 was assessed by tissue microarrays and correlated with disease recurrence. For analysis, we used the test of proportions (chi-square), considering value p<0.05, 95% CI and calculations of sensitivity, specificity and accuracy of these immunomarkers in predicting recurrence. Results : the series comprised 83 patients aged between 16 and 86 years (35±11.7), divided into two groups: 30 with HG-CIN recurrence (study group) and 53 without recurrence (control group). Mean age, parity, smoking and conization technique were similar in both groups. The p53 expression was present in 43% of the study group and 57% of the control group, and the p16 was present in 43% of the study group and in 57% of the control group (p>0.05). p53 had a positive predictive value (PPV) of 42% and negative predictive value (NPV) of 73%, sensitivity 70%, specificity of 47% and accuracy of 59%. The p16, PPV 42%, NPV 72%, sensitivity 66%, specificity of 49% and accuracy of 56%. Conclusion : immunohistochemistry expression of p53 and p16 showed low sensitivity and low specificity as predictors of HG-CIN recurrence after conization treatment.
publishDate 2016
dc.date.none.fl_str_mv 2016-02-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-69912016000100035
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-69912016000100035
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/0100-69912016001008
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Colégio Brasileiro de Cirurgiões
publisher.none.fl_str_mv Colégio Brasileiro de Cirurgiões
dc.source.none.fl_str_mv Revista do Colégio Brasileiro de Cirurgiões v.43 n.1 2016
reponame:Revista do Colégio Brasileiro de Cirurgiões
instname:Colégio Brasileiro de Cirurgiões (CBC)
instacron:CBC
instname_str Colégio Brasileiro de Cirurgiões (CBC)
instacron_str CBC
institution CBC
reponame_str Revista do Colégio Brasileiro de Cirurgiões
collection Revista do Colégio Brasileiro de Cirurgiões
repository.name.fl_str_mv Revista do Colégio Brasileiro de Cirurgiões - Colégio Brasileiro de Cirurgiões (CBC)
repository.mail.fl_str_mv ||revistacbc@cbc.org.br
_version_ 1754209213237690368